Cargando…
Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients
Previous studies showed that aberrant Serine/threonine/tyrosine kinase 1 (STYK1, also known as NOK) or/and E-cadherin were involved in the progression of some types of human cancers. However, whether they contributed to the development of pancreatic cancer was unknown. Here, we investigated the prog...
Autores principales: | Chen, Luguang, Ma, Chao, Bian, Yun, Shao, Chengwei, Wang, Tiegong, Li, Jing, Chong, Xiaodan, Su, Li, Lu, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762325/ https://www.ncbi.nlm.nih.gov/pubmed/29340057 http://dx.doi.org/10.18632/oncotarget.22794 |
Ejemplares similares
-
Low STYK1 expression indicates poor prognosis in gastric cancer
por: Fang, Jian, et al.
Publicado: (2018) -
Aberrant STYK1 expression in ovarian cancer tissues and cell lines
por: Jackson, Kesmic A, et al.
Publicado: (2009) -
CT perfusion based ASPECTS improves the diagnostic performance of early ischemic changes in large vessel occlusion
por: Wang, Tiegong, et al.
Publicado: (2021) -
Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer
por: Huang, Zhao, et al.
Publicado: (2019) -
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe(3)O(4)@SiO(2) nanoprobe modified with anti-mesothelin antibody
por: Liu, Fang, et al.
Publicado: (2016)